KRINTAFEL

This brand name is authorized in United States

Active ingredients

The drug KRINTAFEL contains one active pharmaceutical ingredient (API):

1 Tafenoquine UNII DL5J0B8VSS - TAFENOQUINE SUCCINATE
Tafenoquine is an 8-aminoquinoline antimalarial drug. It is used for the radical cure (prevention of relapse) of Plasmodium vivax malaria in patients aged 16 years and older who are receiving chloroquine therapy for acute P. vivax infection. Read about Tafenoquine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
KRINTAFEL Film‑coated tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: US	FDA, National Drug Code	Identifier(s): 0173-0889

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.